Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

47.34
Delayed Data
As of Jul 30
 -0.16 / -0.34%
Today’s Change
30.05
Today|||52-Week Range
52.33
+47.34%
Year-to-Date
No recent news for Seattle Genetics Inc.

Today’s Trading

Previous close47.50
Today’s open47.25
Day’s range-- - --
Volume820,228
Average volume (3 months)1,004,478
Market cap$5.9B
Dividend yield--
Data as of 07/30/2015

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-35.43%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+6.50%
P/E ratioNM
Price/Sales13.83
Price/Book27.93

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-0.23-0.17%
HZNPHorizon Pharma PLC-0.89-2.39%
IDXXIDEXX Laboratories I...+4.88+7.34%
ICPTIntercept Pharmaceut...-7.67-2.85%
Data as of 07/30/2015

Financials

Last reporting dateJuly 31, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$286.8M
Annual profit (last year)-$76.1M
Net profit margin-26.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts